Gene · 4938
Papers3,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring viral respiratory coinfections: Shedding light on pathogen interactions. | PLoS Pathog | 2024 | 39316558 | PubTator, text mining | PubMed |
| Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study. | Front Genet | 2024 | 39296547 | PubTator, text mining | PubMed |
| Machine learning-based analysis of Ebola virus' impact on gene expression in nonhuman primates. | Front Artif Intell | 2024 | 39282474 | PubTator, text mining | PubMed |
| Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables. | Sci Rep | 2024 | 39237611 | PubTator, text mining | PubMed |
| Evaluation of Laser Intensity Effect on Photodynamic Therapy Efficacy. | J Lasers Med Sci | 2024 | 39193105 | PubTator, text mining | PubMed |
| A non-canonical function of OAS1 to combat viral and bacterial infections. | Immunity | 2024 | 39142270 | PubTator, text mining | PubMed |
Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu-like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll-like receptor 7 agonist ruzotolimod. | Clin Transl Sci | 2024 | 39119977 | PubTator, text mining | PubMed |
| RNA helicase SKIV2L limits antiviral defense and autoinflammation elicited by the OAS-RNase L pathway. | EMBO J | 2024 | 39112803 | PubTator, text mining | PubMed |
Knock down of transforming growth factor beta improves expressions of co-stimulatory molecules, type I interferon-regulated genes, and pro-inflammatory cytokine in PRRSV-inoculated monocyte-derived macrophages. | BMC Vet Res | 2024 | 39097704 | PubTator, text mining | PubMed |
| Genetic predisposition to milder forms of COVID-19 may provide some resilience to head and neck cancers. | Front Oncol | 2024 | 39040446 | PubTator, text mining | PubMed |
| Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses. | PLoS Pathog | 2024 | 39038029 | PubTator, text mining | PubMed |
| Type I interferon gene expression signature as a marker to predict response to cyclophosphamide based treatment in proliferative lupus nephritis. | Lupus | 2024 | 39033304 | PubTator, text mining | PubMed |
| Potential Mechanism and Therapeutic Targets of Polymyositis. | J Coll Physicians Surg Pak | 2024 | 38978245 | PubTator, text mining | PubMed |
| A comparative analysis of RNA-Seq and NanoString technologies in deciphering viral infection response in upper airway lung organoids. | Front Genet | 2024 | 38957806 | PubTator, text mining | PubMed |
| The canonical antiviral protein oligoadenylate synthetase 1 elicits antibacterial functions by enhancing IRF1 translation. | Immunity | 2024 | 38955184 | PubTator, text mining | PubMed |
| Feasibility of Using a Type I IFN-Based Non-Animal Approach to Predict Vaccine Efficacy and Safety Profiles. | Vaccines (Basel) | 2024 | 38932312 | PubTator, text mining | PubMed |
| Genetic association mapping leveraging Gaussian processes. | J Hum Genet | 2024 | 38834722 | PubTator, text mining | PubMed |
| Knockdown of EIF2AK2-OAS1 axis reduces ATP production inducing AMPK phosphorylation to inhibit the malignant behavior of gastric cancer cells. | J Bioenerg Biomembr | 2024 | 38825632 | PubTator, text mining | PubMed |
| The antiviral state of the cell: lessons from SARS-CoV-2. | Curr Opin Immunol | 2024 | 38795501 | PubTator, text mining | PubMed |
| Physiological Consequences of Nonsense-Mediated Decay and Its Role in Adaptive Responses. | Biomedicines | 2024 | 38791071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4938/papers?page=10